Quantum Genomics Société Anonyme (ALQGC.PA)
EUR 0.07
(0.0%)
EUR 0.07
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -830.54 Thousand EUR | 88.73% |
| 2022 | -7.36 Million EUR | 27.0% |
| 2021 | -10.09 Million EUR | 61.58% |
| 2020 | -26.26 Million EUR | -135.33% |
| 2019 | -11.16 Million EUR | 24.51% |
| 2018 | -14.78 Million EUR | -142.94% |
| 2017 | -6.08 Million EUR | -177.07% |
| 2016 | -2.19 Million EUR | 51.74% |
| 2015 | -4.55 Million EUR | -43977.42% |
| 2014 | -10.32 Thousand EUR | -101.44% |
| 2013 | 718.74 Thousand EUR | 96.02% |
| 2012 | 366.66 Thousand EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 1.67 Million EUR | 0.0% |
| 2023 FY | -830.54 Thousand EUR | 88.73% |
| 2023 Q4 | -830.54 Thousand EUR | 0.0% |
| 2023 Q2 | 150.71 Thousand EUR | 0.0% |
| 2022 Q2 | -16.05 Million EUR | 0.0% |
| 2022 FY | -7.36 Million EUR | 27.0% |
| 2022 Q4 | -7.36 Million EUR | 0.0% |
| 2021 FY | -10.09 Million EUR | 61.58% |
| 2021 Q2 | -21.87 Million EUR | 0.0% |
| 2021 Q4 | -10.54 Million EUR | 0.0% |
| 2020 Q4 | -27.15 Million EUR | 0.0% |
| 2020 FY | -26.26 Million EUR | -135.33% |
| 2020 Q2 | -5.83 Million EUR | 0.0% |
| 2019 FY | -11.16 Million EUR | 24.51% |
| 2019 Q2 | -6.62 Million EUR | 0.0% |
| 2019 Q4 | -6.16 Million EUR | 0.0% |
| 2018 Q4 | -14.78 Million EUR | 0.0% |
| 2018 FY | -14.78 Million EUR | -142.94% |
| 2018 Q2 | -5.96 Million EUR | 0.0% |
| 2017 Q2 | -2.31 Million EUR | 0.0% |
| 2017 FY | -6.08 Million EUR | -177.07% |
| 2017 Q4 | -6.08 Million EUR | 0.0% |
| 2016 Q2 | -4.22 Million EUR | 0.0% |
| 2016 FY | -2.19 Million EUR | 51.74% |
| 2016 Q4 | -2.19 Million EUR | 0.0% |
| 2015 Q4 | -4.55 Million EUR | 0.0% |
| 2015 Q2 | -1.04 Million EUR | 0.0% |
| 2015 FY | -4.55 Million EUR | -43977.42% |
| 2014 Q4 | -10.32 Thousand EUR | 0.0% |
| 2014 Q2 | -890.72 Thousand EUR | 0.0% |
| 2014 FY | -10.32 Thousand EUR | -101.44% |
| 2013 FY | 718.74 Thousand EUR | 96.02% |
| 2013 Q4 | 718.74 Thousand EUR | 0.0% |
| 2012 FY | 366.66 Thousand EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| ABIONYX Pharma SA | -714 Thousand EUR | -16.323% |
| ABIVAX Société Anonyme | -196.47 Million EUR | 99.577% |
| Adocia SA | 127 Thousand EUR | 753.975% |
| Aelis Farma SA | -16.19 Million EUR | 94.871% |
| Biophytis S.A. | 2.7 Million EUR | 130.727% |
| Advicenne S.A. | 12.17 Million EUR | 106.822% |
| genOway Société anonyme | 2.97 Million EUR | 127.937% |
| IntegraGen SA | -709.74 Thousand EUR | -17.02% |
| Medesis Pharma S.A. | 1.15 Million EUR | 171.71% |
| Neovacs S.A. | -237.08 Thousand EUR | -250.314% |
| NFL Biosciences SA | -2.27 Million EUR | 63.506% |
| Plant Advanced Technologies SA | 4.35 Million EUR | 119.065% |
| Sensorion SA | 1.37 Million EUR | 160.262% |
| Theranexus Société Anonyme | 2.44 Million EUR | 133.981% |
| TME Pharma N.V. | -1.07 Million EUR | 23.026% |
| Valbiotis SA | -18.13 Million EUR | 95.421% |
| TheraVet SA | 12.78 Thousand EUR | 6596.269% |
| Valerio Therapeutics Société anonyme | 2.18 Million EUR | 138.099% |
| DBV Technologies S.A. | -114.95 Million USD | 99.278% |
| Genfit S.A. | -7.61 Million EUR | 89.088% |
| GeNeuro SA | 5.91 Million EUR | 114.052% |
| Innate Pharma S.A. | -30.71 Million EUR | 97.296% |
| Inventiva S.A. | 10.48 Million EUR | 107.918% |
| MaaT Pharma SA | -10.2 Million EUR | 91.861% |
| MedinCell S.A. | 39.5 Million EUR | 102.103% |
| Nanobiotix S.A. | -24.71 Million EUR | 96.64% |
| OSE Immunotherapeutics SA | 27.12 Million EUR | 103.061% |
| Poxel S.A. | 44.55 Million EUR | 101.864% |
| GenSight Biologics S.A. | 16.29 Million EUR | 105.097% |
| Transgene SA | -14.4 Million EUR | 94.236% |
| Valneva SE | 82.73 Million EUR | 101.004% |